Yahoo Web Search

Search results

1. • Q4 2023 Arcutis Biotherapeutics Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 3 months ago

     Participants Derek Cole; IR; Arcutis Biotherapeutics Inc Frank Watanabe; President & CEO; Arcutis Biotherapeutics Inc L. Todd Edwards; Chief Commercial Officer; Arcutis Biotherapeutics Inc Patrick ...

2. • 

     Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 7 months ago

     Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2023 Earnings Call Transcript November 3, 2023...

3. • Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...

     GuruFocus.com via Yahoo Finance· 3 weeks ago

     Net Product Revenues: $21.6 million for Q1 2024, up 59% from Q4 2023. Gross to Net Percentage: Improved to low 60%s. R&D Expenses: $23.8 million for Q1 2024, flat compared to Q4 2023. SG&A Expenses ...

4. • GBHS theater trip approved for spring of 2024

     Great Bend Tribune, Kan. via Yahoo News· 1 year ago

     Dec. 13—Vocal and instrumental students at Great Bend High School are allowed to take trips every other year, and now the GBHS theater department has been added to the mix. Theater and drama ...